Duke team reaches milestone for LITT procedures
Today, Peter Fecci, MD, PhD, and team were celebrated for hitting the 200-case milestone for laser interstitial thermal therapy (LITT) cases.
Duke researchers publish protocol for processing human spinal cord tumors
Duke researchers have published a novel protocol for collecting and processing human spinal cord tumors during spine surgery for single-cell studies.
Study identifies Duke researchers as top cited in past 20 years for immunotherapy for glioma
A new study of advancements in immunotherapy for glioma analyzed the 100 most cited papers of the past 20 years and concluded that Duke researchers had made the biggest impact in the field.
Duke conducting first-in-human studies of cell transplantation for epilepsy
A groundbreaking clinical trial is taking a new approach to treat seizures: brain cell transplantation.
Drug born at Duke improves survival in people with advanced brain cancer
Ines Batinic-Haberle, PhD, professor emeritus of radiation oncology at Duke University School of Medicine, created hundreds of compounds before she hit upon the right one.
Survey finds link between drug/cannabis use during pregnancy and certain childhood cancers
While the risks of drug use, smoking and drinking during pregnancy are widely accepted, a new survey of parents has identified clear associations between certain types of childhood cancers and gestational substance use, notably cannabis.
Duke Researchers Train AI to Measure Tumor Volume After LITT
While laser interstitial thermal therapy (LITT) is increasingly used to treat brain tumors, it is sometimes associated with cerebral swelling and temporarily worsened symptoms.
Engineering a More Elegant Deep Brain Stimulation Therapy for Parkinson’s
A Duke University team has demonstrated two new strategies that use deep brain stimulation to improve the symptoms of Parkinson’s disease.
Gender may be a prognostic factor in survival and clinical outcomes for patients undergoing treatment for spine metastases
Gender may be a prognostic factor in survival and clinical outcomes for patients undergoing treatment for spine metastases, a new retrospective review by Duke researchers finds.
Duke researchers identify a cell interaction that might drive autoimmune diseases like multiple sclerosis
In a study out today, Duke researchers describe a newly discovered interaction of two specialized cells in the protective covering of the brain (dura).